Lumexa Imaging Q2 net income turns positive
LMRI•Q2 revenue and earnings improve
Lumexa Imaging reported second-quarter revenue of $264.20 million, up 5.1% year over year. Adjusted EPS for the quarter was $0.20, while net income turned positive year over year at $2.74 million. Adjusted EBITDA came in at $56.44 million.
Full-year 2026 outlook reiterated
Lumexa Imaging reiterated 2026 revenue guidance of $1.045 billion to $1.097 billion. It narrowed its 2026 Adjusted EBITDA outlook to $235 million to $241 million, with the midpoint unchanged. The company maintained 2026 Adjusted EPS guidance of $0.71 to $0.77.
Analyst sentiment and price target
The current average analyst rating on the shares is strong buy, with 8 strong buy or buy recommendations and no hold, sell, or strong sell ratings. The median 12-month price target is $18.00, about 54.4% above the stock's August 11 closing price of $11.66.
